分析重症肺炎进展的危险因素在克拉米迪亚psittaci感染:一个回顾性研究
1Department of Prevention and Health Care, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang, 321000, People's Republic of China.
International journal of general medicine
|September 24, 2025
概括
心血管疾病史和血红蛋白水平下降是严重的肺炎肺炎的关键指标. 使用这些因素和动态监测的早期风险分层可以改善患者的治疗结果.
科学领域:
- 传染性疾病 传染性疾病
- 肺部病理学 肺部病理学
- 医疗信息学 医疗信息学
背景情况:
- 由Chlamydia psittaci引起的病性肺炎是一种严重的动物感染,具有显著的死亡率.
- 识别严重疾病的风险因素对于及时干预和改善患者结果至关重要.
研究的目的:
- 为了确定与严重的肺炎肺炎相关的风险因素.
- 评估用于识别严重病例的模型的预测性能.
主要方法:
- 一项追溯研究,对51名患者进行了基因组下一代测序 (mNGS) 确认的肺炎.
- 根据疾病严重程度分类为严重 (n=20) 和不严重 (n=31) 组.
- 使用LASSO回归和Firth-penalized物流回归进行分析,并使用ROC分析进行预测性绩效评估.
主要成果:
- 严重的肺炎患者年龄较大,患有更多的潜在和心血管疾病 (CVD).
- 确定的主要预测因素包括心血管疾病史,淋巴细胞计数 (LYM),血红蛋白 (Hb) 水平和乳酸脱酶 (LDH).
- 心血管疾病史和下降的第二次Hb测量是独立的风险因素;一个多变量模型显示了高的歧视性性能 (AUC=0.885).
结论:
- 心血管疾病病史和逐渐降低的血红蛋白是严重的肺结核肺炎的独立风险因素.
- 动态监测LYM,Hb,LDH和CVD病史有助于早期风险分层.
- 开发的多变量模型显示了对严重的肺病肺炎的高预测准确性和临床实用性.
相关概念视频
Pneumonia III: Complications and Assessment
788
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
788
Pneumonia I: Introduction
734
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
734
Pneumonia II: Pathophysiology
2.6K
The pathophysiology of pneumonia involves the following steps:
2.6K
Bacterial Phylum Chlamydiae
428
The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic...
428
Pneumonia IV: Management
756
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
756
Chronic Obstructive Pulmonary Disease-I: Introduction
3.6K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.6K


